PHARMA NEWS

Health OK tablets

Mankind Pharma launchES ‘Health OK’ tablets

Mankind Pharma expands its OTC portfolio by  launching ‘Health OK’ tablets : Mankind Pharma has been actively expanding its OTC[1] range of products these days. Recently, this pharma company incorporated a new product called ‘Health OK’ tablets under its OTC portfolio. This is a multivitamin tablet and food supplement. The company claimed that ‘Health OK’ …

Mankind Pharma launchES ‘Health OK’ tablets Read More »

Zydus and Alembic

Zydus and Alembic initiate a recall of 2 drugs in the US

Zydus Cadila and Alembic Pharma initiate a nationwide recall of 2 drugs in the US following complaints : The US[1] health regulator, USFDA[2], has recently posted two separate announcements on its website. These announcements state the voluntary recall of some products by two major pharma firms in the US. The two pharma firms that have …

Zydus and Alembic initiate a recall of 2 drugs in the US Read More »

IndoHealth Services

Why Indian Pharma investing in IndoHealth Services?

Sun Pharma and Cadila, along with two other pharma firms, invest around Rs. 40 crore each in ABCD Technologies : Four drug majors have recently announced that they have subscribed to partnership interest in a healthcare services firm. The drug majors involved are Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma. These companies have invested …

Why Indian Pharma investing in IndoHealth Services? Read More »

Aleor Dermaceuticals

USFDA approves antifungal cream of Aleor

Aleor Dermaceuticals, a joint venture of Alembic Pharma gets the USFDA approval for its generic antifungal cream : On 1 April 2021, Alembic Pharma made an announcement regarding its joint venture Aleor Dermaceuticals. It stated that the latter had received the USFDA’s[1] approval for a generic antifungal cream. This generic version contains Nystatin and Triamcinolone …

USFDA approves antifungal cream of Aleor Read More »

Stelis Pharma

Stelis Pharma to supply Sputnik V for India

Stelis Pharma partners with Russia’s sovereign wealth fund to supply 200 million doses of Sputnik V for India Stride Pharma’s subsidiary Stelis Biopharma has partnered with Russia’s sovereign wealth fund regarding Sputnik V production. This collaboration aims to produce and supply over 200 million doses of the COVID – 19 vaccines for India. Strides Pharma …

Stelis Pharma to supply Sputnik V for India Read More »